or Try an Advanced Search...

    Technical Analysis for SGMT - Sagimet Biosciences Inc.

    Grade Last Price % Change Price Change
    D 4.52 2.49% 0.11
    SGMT closed up 2.49 percent on Wednesday, November 20, 2024, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Down Down
    Historical SGMT trend table...
    Date Alert Name Type % Chg
    MACD Bearish Centerline Cross Bearish 0.00%
    Crossed Above 200 DMA Bullish 0.00%
    NR7 Range Contraction 0.00%
    Lower Bollinger Band Walk Weakness 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Lower Bollinger Band Touch Weakness 0.00%
    Oversold Stochastic Weakness 0.00%
    200 DMA Resistance Bearish 2.49%
    50 DMA Resistance Bearish 2.49%
    Older End-of-Day Signals for SGMT ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 18 hours ago
    Possible Inside Day about 18 hours ago
    Rose Above 200 DMA about 20 hours ago
    Down 3% about 22 hours ago
    Rose Above Lower Bollinger Band about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    SGMT Chart by TradingView
    Basic chart:

    Profile

    Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors to treat important diseases, such as non-alcoholic steatohepatitis, acne, and various cancers. It offers Denifanstat, a fatty acid synthase inhibitor for the treatment of nonalcoholic steatohepatitis. The company also develops TVB-3567, a FASN inhibitor. Sagimet Biosciences Inc. was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. The company was incorporated in 2006 and is based in San Mateo, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biopharmaceutical Cancer Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Acne

    Is SGMT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Sagimet Biosciences Presents Clinical Denifanstat and Preclinical FASN Inhibitor Data at AASLD - The Liver Meeting® 2024
    Nov 18 Institutional investors in Sagimet Biosciences Inc. (NASDAQ:SGMT) see US$36m decrease in market cap last week, although long-term gains have benefitted them.
    Nov 14 Sagimet: More Than Just A MASH Drug Development Biotech
    Nov 14 Sagimet Biosciences GAAP EPS of -$0.45
    Nov 14 Sagimet Biosciences Reports Third Quarter 2024 Financial Results and Provides Corporate Updates
    Nov 12 Sagimet draws buy at UBS on MASH opportunity
    Nov 7 Sagimet Biosciences to Participate in the UBS Global Healthcare Conference
    Oct 29 Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024
    Oct 18 Sagimet Soars: FDA Breakthrough Therapy Designation And Lancet Review Validate Denifanstat
    Oct 16 Sagimet Biosciences Announces Upcoming Presentations at AASLD - The Liver Meeting® 2024
    See more SGMT news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 20.71
    52 Week Low 2.39
    Average Volume 1,744,034
    200-Day Moving Average 4.46
    50-Day Moving Average 4.58
    20-Day Moving Average 5.46
    10-Day Moving Average 5.31
    Average True Range 0.51
    RSI (14) 40.48
    ADX 30.36
    +DI 20.35
    -DI 26.78
    Chandelier Exit (Long, 3 ATRs) 4.86
    Chandelier Exit (Short, 3 ATRs) 5.73
    Upper Bollinger Bands 6.57
    Lower Bollinger Band 4.34
    Percent B (%b) 0.08
    BandWidth 40.98
    MACD Line -0.01
    MACD Signal Line 0.23
    MACD Histogram -0.2398
    Fundamentals Value
    Market Cap 137.3 Million
    Num Shares 30.4 Million
    EPS -1.18
    Price-to-Earnings (P/E) Ratio -3.83
    Price-to-Sales 99.52
    Price-to-Book 1.96
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.94
    Resistance 3 (R3) 4.90 4.72 4.87
    Resistance 2 (R2) 4.72 4.62 4.74 4.84
    Resistance 1 (R1) 4.62 4.55 4.67 4.66 4.82
    Pivot Point 4.45 4.45 4.47 4.46 4.45
    Support 1 (S1) 4.34 4.34 4.40 4.38 4.22
    Support 2 (S2) 4.17 4.27 4.19 4.20
    Support 3 (S3) 4.07 4.17 4.17
    Support 4 (S4) 4.10